Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis Journal:Asian Pacific Journal of Cancer Prevention | 2013 | 90 | ||
Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? Journal:Hepatology Communications | 15-May-2023 | |||
Preliminary efficacy of neoadjuvant nab-paclitaxel and pembrolizumab-containing regimens in early staged triple negative breast cancer (ETNBC) therapy (Oral presentation) Proceeding/Conference:Global Breast Cancer Conference 2023 (27/04/2023-29/04/2023, Seoul) | 27-Apr-2023 |